Published in Bone Marrow Transplant on August 01, 1997
Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells. Clin Exp Immunol (2008) 0.85
Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients. Rheumatol Int (2005) 0.78
Inhibition of Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro. Clin Exp Immunol (2000) 0.76
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet (1993) 3.87
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med (1991) 2.93
Y-antigen killing by T cells of women is restricted by HLA. Nature (1977) 2.73
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet (2005) 2.65
A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity (1997) 2.45
The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science (1998) 2.11
Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer. N Engl J Med (1990) 1.99
Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann Neurol (1999) 1.99
A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectives. Eur J Cancer Clin Oncol (1989) 1.91
The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity (1997) 1.78
Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma. Lancet (1984) 1.77
Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature (1992) 1.76
Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol (1999) 1.68
T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation. Eur J Immunol (1986) 1.62
Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood (1995) 1.58
Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol (1992) 1.55
Bivariate random effects meta-analysis of ROC curves. Med Decis Making (2008) 1.54
Score test for detecting linkage to quantitative traits. Genet Epidemiol (2002) 1.53
Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro. Transplantation (2001) 1.46
On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients. J Invest Dermatol (1991) 1.44
The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods (1994) 1.43
Permanent detrimental effect of nonimmunological factors on long-term renal graft survival: a parsimonious model of time-dependency. Transplantation (2000) 1.42
Renal allograft rejection and antibodies to epithelial cells. Lancet (1992) 1.42
Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens. Transplantation (2001) 1.41
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression. Transplantation (2001) 1.39
Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. J Immunol (1999) 1.38
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38
Impact of Huntington's disease on quality of life. Mov Disord (2001) 1.37
Immunomodulation by intrathymic injection of donor leukocytes in rhesus monkeys. Transplantation (2001) 1.37
Inhaled corticosteroids and growth of airway function in asthmatic children. Eur Respir J (2004) 1.36
A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature (1983) 1.34
Thrombocytopenia and leucopenia with mianserin-dependent antibodies. Br J Clin Pharmacol (1985) 1.25
Cell-mediated lympholysis studies in renal allograft recipients. Transplantation (1981) 1.25
Meta-analysis of pairs of survival curves under heterogeneity: a Poisson correlated gamma-frailty approach. Stat Med (2009) 1.21
Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology (1988) 1.20
Alloimmunity to human H-Y. Lancet (1976) 1.20
Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet (1990) 1.19
Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens (1998) 1.18
Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol (2001) 1.15
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol (2001) 1.14
Platelet and granulocyte specific allo-antigens in chimpanzees. Tissue Antigens (1983) 1.14
Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost (1988) 1.14
Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol (1995) 1.12
Anti-self HLA may be clonally expressed. J Exp Med (1979) 1.10
Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics (1992) 1.10
Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood (1994) 1.08
In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal. Transplantation (1996) 1.07
Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid? J Reprod Immunol (2000) 1.07
Antimicrobial treatment in acute maxillary sinusitis: a meta-analysis. J Clin Epidemiol (1997) 1.06
Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells. J Clin Invest (1988) 1.05
Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells. J Exp Med (1988) 1.03
The importance of H-Y incompatibility in human organ transplantation. Transplantation (1978) 1.03
Risk estimation for healthy women from breast cancer families: new insights and new strategies. Cancer Epidemiol Biomarkers Prev (2004) 1.02
Existence of mature human CD4+ T cells with genuine class I restriction. Eur J Immunol (1992) 1.02
Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. Eur J Surg Oncol (1998) 1.01
HLA restriction of non-HLA--A, --B, --C and --D cell mediated lympholysis (CML). Tissue Antigens (1976) 1.01
Serum cytokine levels after HLA-identical bone marrow transplantation. Transplantation (1998) 1.01
Interaction of penicillin with HLA-A and -B antigens. Hum Immunol (1982) 1.01
Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med (1989) 1.01
Analysis of the renal transplant waiting list: application of a parametric competing risk method. Transplantation (1998) 1.00
Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol (1986) 1.00
Sex ratio of the mutation frequencies in haemophilia A: estimation and meta-analysis. Hum Genet (1990) 1.00
Major histocompatibility complex-restricted antibody reactivity mainly, but not exclusively, directed against cells from male donors. J Exp Med (1979) 0.99
Distribution of endothelial-monocyte and HLA antigens on renal vascular endothelium. Transplant Proc (1981) 0.98
Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum Immunol (2001) 0.98
Demonstration of granulocyte, monocyte, and endothelial cell antigens by double fluorochromatic microcytotoxicity testing. Transplant Proc (1980) 0.98
Sensitivity and specificity of diagnostic tests in acute maxillary sinusitis determined by maximum likelihood in the absence of an external standard. J Clin Epidemiol (1994) 0.98
Detection of platelet antibodies by enzyme-linked immunosorbent assay (ELISA) on artificial monolayers of platelets. Immunol Lett (1981) 0.97
In the queue for a cadaver donor kidney transplant: new rules and concepts in the Eurotransplant International Foundation. Nephrol Dial Transplant (2000) 0.97
Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL. J Immunol (1997) 0.97
Sex ratio of the mutation frequencies in haemophilia A: coagulation assays and RFLP analysis. J Med Genet (1991) 0.97
Expression of HLA class I antigens in transporter associated with antigen processing (TAP)-deficient mutant cell lines. Tissue Antigens (1998) 0.96
Morphometric study of histological changes in sublabial salivary glands due to aging process. J Clin Pathol (1986) 0.95
Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation (1999) 0.95
Accelerated rejection of a renal allograft associated with pretransplantation antibodies directed against donor antigens on endothelium and monocytes. N Engl J Med (1979) 0.94
Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. Lancet (1996) 0.93
Characterization of the ABO blood group genes in macaques: evidence for convergent evolution. Tissue Antigens (1998) 0.93
Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice. Leukemia (2006) 0.93
Weighted statistics for aggregation and linkage analysis of human longevity in selected families: the Leiden Longevity Study. Stat Med (2009) 0.93
Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol (1993) 0.93
Beneficial effect of HLA-DR matching on the survival of corneal allografts. Transplantation (2000) 0.92
Quality of life in couples living with Huntington's disease: the role of patients' and partners' illness perceptions. Qual Life Res (2007) 0.92
Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients. Am J Transplant (2013) 0.92
Much ado about minor histocompatibility antigens. Immunol Today (1998) 0.92
Felty syndrome: autoimmune neutropenia or immune-complex-mediated disease? Rheumatol Int (1985) 0.92
The effect of HLA matching on kidney graft survival in separate posttransplantation intervals. Transplantation (1990) 0.92
Typing for MLC (LD). I. Lymphocytes from cousin-marriage offspring as typing cells. Transplant Proc (1973) 0.92
New facts on HLA genetics: are they relevant in bone marrow transplantation? Semin Hematol (1984) 0.92
Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist. Qual Life Res (2003) 0.91